Revvity | PKI - Fremdkapital





Fremdkapital Veränderung Datum
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Celltrion KRW 412.27B 348.97B 2025-12
Charles River Laboratories USD 2.66B 526.77M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
Illumina USD 1.49B 0 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.99B 105M 2026-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Laboratory Of America USD 5.9B 748.3M 2026-03
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Mesa Laboratories USD 104.2M 104.3M 2024-09
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pharma Mar EUR 33.16M 3.52M 2026-03
Qiagen NV USD 1.65B 15.23M 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Quidel USD 0 2.47B 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
Sartorius EUR 3.34B 152.8M 2026-03
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Tilray USD 268.59M 3.82M 2025-09
Waters USD 5.22B 3.81B 2026-03
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03